Skip to main content
Premium Trial:

Request an Annual Quote

Predictive Biosciences, Affinity Collaborate on Assay Development

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Predictive Biosciences and Affinity Life Sciences today said they are collaborating to develop biomarker assays for use in clinical studies.

Financial and other terms of the deal were not disclosed.

In a statement, Predictive Bio, based in Lexington, Ky., said the collaboration provides it with access to Affinity's expertise in biomarker immunoassay development. It added that with Affinity's support it will expand its cancer diagnostic menu.

Predictive develops molecular diagnostic cancer assays and provides anatomic pathology laboratory solutions. Affinity is a contract research organization based in Milford, NH, specializing in biomarker and immunochemistry assay development for research use or under cGMP conditions.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.